Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1991;84(Suppl 18):7–9.

Neonatal screening--should we or shouldn't we?

P H Weller 1, J V West 1
PMCID: PMC1293029  PMID: 2033575

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowling F. G., McGill J. J., Shepherd R. W., Danks D. M. Screening for cystic fibrosis: use of delta F508 mutation. Lancet. 1990 Apr 14;335(8694):925–926. doi: 10.1016/0140-6736(90)90534-c. [DOI] [PubMed] [Google Scholar]
  2. Bowling F., Cleghorn G., Chester A., Curran J., Griffin B., Prado J., Francis P., Shepherd R. Neonatal screening for cystic fibrosis. Arch Dis Child. 1988 Feb;63(2):196–198. doi: 10.1136/adc.63.2.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chatfield S., Owen G., Ryley H. C., Williams J., Alfaham M., Goodchild M. C., Weller P. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child. 1991 Jan;66(1 Spec No):29–33. doi: 10.1136/adc.66.1_spec_no.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crossley J. R., Elliott R. B., Smith P. A. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979 Mar 3;1(8114):472–474. doi: 10.1016/s0140-6736(79)90825-0. [DOI] [PubMed] [Google Scholar]
  5. Dankert-Roelse J. E., te Meerman G. J., Martijn A., ten Kate L. P., Knol K. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr. 1989 Mar;114(3):362–367. doi: 10.1016/s0022-3476(89)80552-9. [DOI] [PubMed] [Google Scholar]
  6. Desai N., Nousia-Arvanitakis S. False negative meconium test results in screening for cystic fibrosis. J Pediatr. 1977 Sep;91(3):447–448. doi: 10.1016/s0022-3476(77)81322-x. [DOI] [PubMed] [Google Scholar]
  7. Heeley A. F., Heeley M. E., King D. N., Kuzemko J. A., Walsh M. P. Screening for cystic fibrosis by died blood spot trypsin assay. Arch Dis Child. 1982 Jan;57(1):18–21. [PMC free article] [PubMed] [Google Scholar]
  8. Littlewood J. M. The sweat test. Arch Dis Child. 1986 Nov;61(11):1041–1043. doi: 10.1136/adc.61.11.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McIntosh I., Lorenzo M. L., Brock D. J. Frequency of delta F508 mutation on cystic fibrosis chromosomes in UK. Lancet. 1989 Dec 9;2(8676):1404–1405. doi: 10.1016/s0140-6736(89)92025-4. [DOI] [PubMed] [Google Scholar]
  10. Orenstein D. M., Boat T. F., Stern R. C., Tucker A. S., Charnock E. L., Matthews L. W., Doershuk C. F. The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs. Am J Dis Child. 1977 Sep;131(9):973–975. doi: 10.1001/archpedi.1977.02120220039005. [DOI] [PubMed] [Google Scholar]
  11. Roberts G., Stanfield M., Black A., Redmond A. Screening for cystic fibrosis: a four year regional experience. Arch Dis Child. 1988 Dec;63(12):1438–1443. doi: 10.1136/adc.63.12.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rock M. J., Mischler E. H., Farrell P. M., Wei L. J., Bruns W. T., Hassemer D. J., Laessig R. H. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics. 1990 Jun;85(6):1001–1007. [PubMed] [Google Scholar]
  13. Ryley H. C., Deam S. M., Williams J., Alfaham M., Weller P. H., Goodchild M. C., Carter R. A., Bradley D., Dodge J. A. Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test. J Clin Pathol. 1988 Jul;41(7):726–729. doi: 10.1136/jcp.41.7.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shwachman H., Redmond A., Khaw K. T. Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics. 1970 Sep;46(3):335–343. [PubMed] [Google Scholar]
  15. Wilcken B., Brown A. R., Urwin R., Brown D. A. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J Pediatr. 1983 Mar;102(3):383–387. doi: 10.1016/s0022-3476(83)80653-2. [DOI] [PubMed] [Google Scholar]
  16. Wilcken B., Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet. 1985 Dec 14;2(8468):1319–1321. doi: 10.1016/s0140-6736(85)92623-6. [DOI] [PubMed] [Google Scholar]
  17. Wilcken B., Towns S. J., Mellis C. M. Diagnostic delay in cystic fibrosis: lessons from newborn screening. Arch Dis Child. 1983 Nov;58(11):863–866. doi: 10.1136/adc.58.11.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. al-Jader L. N., Goodchild M. C., Ryley H. C., Harper P. S. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet. 1990 Dec;38(6):460–465. doi: 10.1111/j.1399-0004.1990.tb03613.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES